×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DXCM – dexcom, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DXCM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/3
08:30 am
dxcm
Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.
Medium
Report
Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.
4/1
09:10 am
dxcm
DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns [Yahoo! Finance]
Low
Report
DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns [Yahoo! Finance]
4/1
08:00 am
dxcm
Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems
Low
Report
Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems
3/26
08:13 pm
dxcm
DexCom (NasdaqGS:DXCM) Expands Wearable Integration and Appoints New Chief Commercial Officer [Yahoo! Finance]
Medium
Report
DexCom (NasdaqGS:DXCM) Expands Wearable Integration and Appoints New Chief Commercial Officer [Yahoo! Finance]
3/26
12:32 pm
dxcm
Dexcom's FDA warning letter reveals unauthorized changes to sensors [Yahoo! Finance]
Low
Report
Dexcom's FDA warning letter reveals unauthorized changes to sensors [Yahoo! Finance]
3/25
05:04 pm
dxcm
Dexcom Appoints Jon Coleman as Chief Commercial Officer [Yahoo! Finance]
Low
Report
Dexcom Appoints Jon Coleman as Chief Commercial Officer [Yahoo! Finance]
3/25
04:05 pm
dxcm
Dexcom Appoints Jon Coleman as Chief Commercial Officer
Low
Report
Dexcom Appoints Jon Coleman as Chief Commercial Officer
3/25
07:13 am
dxcm
DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at Cfra Research to a "hold" rating.
Low
Report
DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at Cfra Research to a "hold" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/31
06:57 pm
dxcm
Form 3 DEXCOM INC For: Mar 31 Filed by: Coleman Jon
Low
Report
Form 3 DEXCOM INC For: Mar 31 Filed by: Coleman Jon
3/27
09:04 am
dxcm
Form ARS DEXCOM INC For: Dec 31
Medium
Report
Form ARS DEXCOM INC For: Dec 31
3/27
09:02 am
dxcm
Form DEF 14A DEXCOM INC For: May 08
Medium
Report
Form DEF 14A DEXCOM INC For: May 08
3/25
04:30 pm
dxcm
Form 8-K DEXCOM INC For: Mar 21
Low
Report
Form 8-K DEXCOM INC For: Mar 21
3/19
05:02 pm
dxcm
Form 4 DEXCOM INC For: Mar 17 Filed by: Heller Bridgette P
Low
Report
Form 4 DEXCOM INC For: Mar 17 Filed by: Heller Bridgette P
3/17
09:40 am
dxcm
Form 144 DEXCOM INC Filed by: Heller Bridgette P
Low
Report
Form 144 DEXCOM INC Filed by: Heller Bridgette P
3/14
05:26 pm
dxcm
Form 4 DEXCOM INC For: Mar 12 Filed by: Leach Jacob Steven
Low
Report
Form 4 DEXCOM INC For: Mar 12 Filed by: Leach Jacob Steven
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/6
Q3/2019 9/30/2019 EPS 0.650 ZacksConsensus 0.200 ActVsEst 0.450 - Beat
27.2%
2/13 Q4/2019 12/31/2019 EPS 1.150 ZacksConsensus 0.750 ActVsEst 0.400 - Beat 12.0%
4/28 Q1/2020 3/31/2020 EPS 0.440 ZacksConsensus 0.100 ActVsEst 0.340 - Beat 10.3%
4/8 Form 4 DEXCOM INC For: Apr 07 Filed by: SAYER KEVIN R 7.9%
4/15 Top-Ranked Medical Duo Breaks Out — But Only One Holds Onto Its Gain [Investor's Business Daily] 4.9%
4/1 Form 4 DEXCOM INC For: Mar 30 Filed by: Selvaraj Shelly Ramasamy 4.9%
6/11 Form 4 DEXCOM INC For: Jun 10 Filed by: SAYER KEVIN R 4.9%
3/9 Form 4 DEXCOM INC For: Mar 05 Filed by: Pacelli Steven Robert 4.8%
2/14 IBD 50 Watchlist Of Growth Stocks Adds Nvidia, Tradeweb, Veeva, Wex [Investor's Business Daily] 4.6%
3/25 Form 4 DEXCOM INC For: Mar 13 Filed by: DOUBLEDAY RICHARD 4.5%
2/13 Q4/2019 12/31/2019 EPS 1.150 ZacksConsensus 0.750 ActVsEst 0.400 - Beat 12.0%
4/28 Q1/2020 3/31/2020 EPS 0.440 ZacksConsensus 0.100 ActVsEst 0.340 - Beat 10.3%
4/8 Form 4 DEXCOM INC For: Apr 07 Filed by: SAYER KEVIN R 7.9%
4/15 Top-Ranked Medical Duo Breaks Out — But Only One Holds Onto Its Gain [Investor's Business Daily] 4.9%
4/1 Form 4 DEXCOM INC For: Mar 30 Filed by: Selvaraj Shelly Ramasamy 4.9%
6/11 Form 4 DEXCOM INC For: Jun 10 Filed by: SAYER KEVIN R 4.9%
3/9 Form 4 DEXCOM INC For: Mar 05 Filed by: Pacelli Steven Robert 4.8%
2/14 IBD 50 Watchlist Of Growth Stocks Adds Nvidia, Tradeweb, Veeva, Wex [Investor's Business Daily] 4.6%
3/25 Form 4 DEXCOM INC For: Mar 13 Filed by: DOUBLEDAY RICHARD 4.5%
TOP News Decliners
3/14
Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep Vertex, Biogen, Dexcom, Eli Lilly, Masimo Under Observation [Investor's Business Daily]
-15.6%
3/10 Form 8-K DEXCOM INC For: Mar 10 -9.6%
9/7 DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -9.4%
8/1 DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Robert W. Baird from $180.00 to $186.00. They now have an "outperform" rating on the stock. -7.5%
4/27 DexCom Q1 2020 Earnings Preview [Seeking Alpha] -7.0%
10/8 Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM -5.9%
3/19 Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM) [Yahoo! Finance News] -5.4%
7/2 Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time -4.6%
9/5 Form 4 DEXCOM INC For: Sep 03 Filed by: Balo Andrew K -4.4%
2/20 Form 4 DEXCOM INC For: Feb 18 Filed by: Collins Richard Alexander -4.1%
3/10 Form 8-K DEXCOM INC For: Mar 10 -9.6%
9/7 DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -9.4%
8/1 DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Robert W. Baird from $180.00 to $186.00. They now have an "outperform" rating on the stock. -7.5%
4/27 DexCom Q1 2020 Earnings Preview [Seeking Alpha] -7.0%
10/8 Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM -5.9%
3/19 Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM) [Yahoo! Finance News] -5.4%
7/2 Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time -4.6%
9/5 Form 4 DEXCOM INC For: Sep 03 Filed by: Balo Andrew K -4.4%
2/20 Form 4 DEXCOM INC For: Feb 18 Filed by: Collins Richard Alexander -4.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: